Abstract:Rapid developments in Regenerative Medicine and Tissue Engineering has witnessed an increasing drive toward clinical translation of breakthrough technologies. However, the progression of promising preclinical data to achieve successful clinical market authorisation remains a bottleneck. One hurdle for progress to the clinic is the transition from small animal research to advanced preclinical studies in large animals to test safety and efficacy of products. Notwithstanding this, to draw meaningful and reliable conclusions from animal experiments it is critical that the species and disease model of choice is relevant to answer the research question as well as the clinical problem. Selecting the most appropriate animal model requires in-depth knowledge of specific species and breeds to ascertain the adequacy of the model and outcome measures that closely mirror the clinical situation. Traditional reductionist approaches in animal experiments, which often do not sufficiently reflect the studied disease, are still the norm and can result in a disconnect in outcomes observed between animal studies and clinical trials. To address these concerns a reconsideration in approach will be required. This should include a stepwise approach using in vitro and ex vivo experiments as well as in silico modeling to minimize the need for in vivo studies for screening and early development studies, followed by large animal models which more closely resemble human disease. Naturally occurring, or spontaneous diseases in large animals remain a largely untapped resource, and given the similarities in pathophysiology to humans they not only allow for studying new treatment strategies but also disease etiology and prevention. Naturally occurring disease models, particularly for longer lived large animal species, allow for studying disorders at an age when the disease is most prevalent. As these diseases are usually also a concern in the chosen veterinary species they would be beneficiaries of newly developed therapies. Improved awareness of the progress in animal models is mutually beneficial for animals, researchers, human and veterinary patients. In this overview we describe advantages and disadvantages of various animal models including domesticated and companion animals used in regenerative medicine and tissue engineering to provide an informed choice of disease-relevant animal models.

Progress and promise of alternative animal and non-animal methods in biomedical research

Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches

A Review on Alternative Methods to Experimental Animals in Biological Testing: Recent Advancement and Current Strategies

Poor Translatability of Biomedical Research Using Animals — A Narrative Review

Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods

Animal models in neuroscience with alternative approaches: Evolutionary, biomedical, and ethical perspectives

An Overview of Current Alternative Models for Use in the Context of Prostate Cancer Research

They See a Rat, We Seek a Cure for Diseases: The Current Status of Animal Experimentation in Medical Practice

Impact of quality and transparency in scientific writing on the reduction of animal usage in experimental protocols: a review based in pertinent literature

EURL ECVAM Literature Review Series on Advanced Non-Animal Models for Respiratory Diseases, Breast Cancer and Neurodegenerative Disorders

Mitigating animal methods bias to reduce animal use and improve biomedical translation

Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Second International Conference on 3Rs Research and Progress, Hyderabad, 2021

Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do

The Implementation of the Three Rs in Regulatory Toxicity and Biosafety Assessment: The Indian Perspective

The Importance of Animal Models in Biomedical Research: Current Insights and Applications

Current views on in vivo models for breast cancer research and related drug development

Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing

A Comprehensive Review on Redundancy usage of Animal models in Novel Drug testing

A Brief History of Use of Animals in Biomedical Research and Perspective on Non-Animal Alternatives

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy

An analysis of trends in the use of animal and non-animal methods in biomedical research and toxicology publications